Sichuan, China

Deng Jiao Ma


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Deng Jiao Ma in Antibacterial Medicaments

Introduction

Deng Jiao Ma is an accomplished inventor based in Sichuan, China. He has made significant contributions to the field of antibacterial medicaments through his innovative research and development. His work focuses on human-originated EGF domain proteins and their applications in treating infections caused by Gram-negative bacteria.

Latest Patents

Deng Jiao Ma holds a patent for "Human originated EGF domain proteins and use of the same." This invention involves detecting the minimum inhibitory concentrations of human-originated EGF domain proteins against various Gram-negative bacteria, demonstrating their in vitro antibacterial activity. The findings indicate that these proteins have a notable inhibitory effect on Gram-negative bacteria, paving the way for the development of a new class of medicaments aimed at treating such infections. Additionally, it has been shown that these proteins can hydrolyze and eliminate endotoxins, further supporting the creation of novel treatments for endotoxemia. The amino acid sequences of these proteins are described in SEQ ID NO: 1 or those with over 50% homology to this sequence.

Career Highlights

Deng Jiao Ma is currently associated with Chengdu Sourcebio Limited Liability Company, where he continues to advance his research in the field of medicinal proteins. His work has garnered attention for its potential impact on public health, particularly in combating antibiotic-resistant bacteria.

Collaborations

Deng Jiao Ma collaborates with notable colleagues, including Xu Song and Ling Li, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Deng Jiao Ma's contributions to the field of antibacterial medicaments through his patent on human-originated EGF domain proteins highlight the importance of innovation in medical research. His work not only addresses critical health challenges but also opens new avenues for treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…